Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
705
-
Total 13F shares, excl. options
-
198M
-
Shares change
-
+720K
-
Total reported value, excl. options
-
$3.78B
-
Value change
-
+$7.47M
-
Put/Call ratio
-
0.51
-
Number of buys
-
294
-
Number of sells
-
-326
-
Price
-
$19.13
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q3 2024
805 filings reported holding OGN - Organon & Co. - Common Stock as of Q3 2024.
Organon & Co. - Common Stock (OGN) has 705 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 198M shares
of 260M outstanding shares and own 76.03% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (32.1M shares), VANGUARD GROUP INC (30.2M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (9.76M shares), STATE STREET CORP (8.98M shares), LSV ASSET MANAGEMENT (7.49M shares), NORDEA INVESTMENT MANAGEMENT AB (6.74M shares), SOUND SHORE MANAGEMENT INC /CT/ (5.14M shares), MORGAN STANLEY (5.12M shares), DEPRINCE RACE & ZOLLO INC (4.42M shares), and GEODE CAPITAL MANAGEMENT, LLC (4.25M shares).
This table shows the top 705 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.